Search results
Exelixis, Inc.'s (NASDAQ:EXEL) Financials Are Too Obscure To Link With Current Share Price Momentum:...
Simply Wall St. via Yahoo Finance· 1 year agoExelixis (NASDAQ:EXEL) has had a great run on the share market with its stock up by a significant...
Exelixis, Inc.'s (NASDAQ:EXEL) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend...
Simply Wall St. via Yahoo Finance· 2 months agoExelixis' (NASDAQ:EXEL) stock is up by a considerable 16% over the past month. However, we decided...
Exelixis (EXEL) Q2 Earnings Top, Cabometyx Drives Growth
Zacks via Yahoo Finance· 9 months agoExelixis, Inc. EXEL reported earnings of 31 cents per share in the first quarter of 2023, which...
Institutional investors in Exelixis, Inc. (NASDAQ:EXEL) lost 3.8% last week but have reaped the...
Simply Wall St. via Yahoo Finance· 4 weeks agoKey Insights Significantly high institutional ownership implies Exelixis' stock price is sensitive...
Exelixis (EXEL) Q1 Earnings Miss, Cabometyx Sales Fall Short
Zacks via Yahoo Finance· 2 weeks agoExelixis, Inc. EXEL reported lower-than-expected results for the first quarter. Its shares fell 7%...
Exelixis, Inc.'s (NASDAQ:EXEL) market cap decline of US$208m may not have as much of an impact on...
Simply Wall St. via Yahoo Finance· 12 months agoKey Insights Significantly high institutional ownership implies Exelixis' stock price is sensitive...
Exelixis (EXEL) Q4 Earnings Beat on Lower R&D Spend, Sales Miss
Zacks via Yahoo Finance· 3 months agoExelixis, Inc. EXEL reported earnings of 33 cents per share in the fourth quarter of 2023, which...
Exelixis (EXEL) Q4 Earnings Top, Revenues Beat on Cabometyx
Zacks via Yahoo Finance· 1 year agoExelixis, Inc. EXEL reported a loss of 3 cents per share for the fourth quarter of 2022, compared to...
Exelixis (EXEL) Q3 Earnings and Sales Miss, Annual View Updated
Zacks via Yahoo Finance· 6 months agoExelixis, Inc. EXEL reported earnings of 10 cents per share in the third quarter of 2023, which...
Exelixis (EXEL) Gets Rights for Tumor Candidate From Insilico
Zacks via Yahoo Finance· 8 months agoExelixis, Inc.’s EXEL efforts to develop its oncology pipeline took another step forward when it...